Twenty-Four-Month OCTA Assessment in Diabetic Patients Undergoing Fixed-Interval Intravitreal Aflibercept Therapy.
暂无分享,去创建一个
Rishi P. Singh | P. Kaiser | A. Rachitskaya | A. Yuan | A. Schachat | Felipe F. Conti | Fabiana Q. Silva | Thais F. Conti | A. Babiuch | Brittney Statler